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ABSTRACT

Author: Vadlamani, Ram Anand. PhD
Institution: Purdue University
Degree Received: August 2018
Title: Assessing Novel Bioelectric Effects Of Nanosecond Pulsed Electric Fields On Cell
Stimulation, Proliferation And Microorganism Inactivation
Major Professor: Dr. Allen L. Garner
Bioelectrics is the application of electric fields to cells in a conducting media, treating the cell
as a circuit comprising resistors and capacitors (membranes and intracellular fluids respectively).
Recent advancements in construction of nanosecond pulse generators allow for construction of
low cost devices capable of generating nanosecond pulsed electric fields (nsPEFs). These fields
are capable of forming pores on the extra and intra cellular membranes, while also affecting
intracellular organelles, DNA and the nucleus. With the first generation of nano-signalling devices
set to enter the medical field for treatments ranging from carcinomas to regenerative therapy, the
intent of this study was to examine their effect on the growth dynamics of cancer cells under
treatment and the potential to stimulate stem cells for use in regenerative healing therapies. A novel
application to combat antibiotic resistance in microorganisms was explored.
While pulsed electric fields (PEFs) can control cell population in vitro, the ability to
specifically predict the types of cells (dividing or resting) targeted and optimize the PEF
parameters remain critical challenges for potential cancer treatment applications. Mathematical
models of cancer cell population dynamics based on coupled differential equations can predict the
transition of cells between the proliferating, quiescent, and dead states to predict the progression
of cell population over time. Chapter 2 of this dissertation will experimentally assess the impact
of pulse duration, field intensity, and number of pulses on cell population dynamics and fit the
mathematical model to assess the transition between proliferating, quiescent, and dead states.
These results demonstrate the tenability of nsPEFs for controlling cell number, suggesting the
potential impact of sublethal PEFs on cell populations, which may impact cancer therapy.
Low intensity electric fields can induce changes in cardiomyocyte (heart muscle)
differentiation, increasing the number of beating foci. These fields can also induce cytoskeletal
stresses that facilitate manipulation of osteoblasts and mesenchymal stem cells. While effective,
low intensity DC or AC electric fields require long (tens of minutes) application times, which are
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on the order of physiological mechanisms that can complicate the consistency of the treatments.
We hypothesized that intense nanosecond pulsed electric fields (nsPEFs) can overcome these side
effects by inducing similar stresses on a timescale shorter than physiological processes while
additionally inducing plasma membrane nanoporation, ion transport, and intracellular structure
manipulation. Chapter 3 of this dissertation examines the impact of pulse duration, field intensity
and number of pulses on muscle stem cell population dynamics, demonstrating increased
proliferation on a photospectrometer and observed increased differentiation under fluorescent
microscopy.
The increasing prevelance of antibiotic resistance mechanisms that render current antibiotics
ineffective while requiring greater cytotoxicity and concentrations of newer and more powerful
drugs to treat infections necessitates the design of new treatments by combining nsPEFs with
antibiotics and combinations of antibiotics. This dissertation demonstrates the synergistic
inactivation of clinically relevant gram negative Escherichia coli and gram positive
Stapphylococcus aureus. Low electric fields which have no effect on gram positive microorganism
populations by themselves, produced a 2.5 log reduction of bacterial colony forming units when
combined with 1/20th of the clinical dose of certain antibiotics. This synergistic effect was
magnified with an increase in drug concentration and an increase in field strength, individually. In
combination, this leads to complete sterilization (a 9-log reduction) in colony forming units.

1

1. INTRODUCTION & LITERATURE REVIEW

Nanosecond pulsed electric fields (nsPEFs) have become a growing field of research for
their potential in biomedical, food pasteurization and sterilization applications[1]–[4]. Pulsed
power is not a recent creation, with high power pulse generators powering the first stages of radars,
microwave generating devices, lasers, tasers, plasma combustors and tokamaks, as shown in
Figure 1. Their miniaturization combined with technical advancements has enabled the application
of nanosecond electric for inducing novel effects in cells and biological systems.

Figure 1: Applications of pulsed power in (a) radar, (b) Z pinch machine (Sandia Natl. Labs), (c)
railguns (General Atomics), (d) Plasma combustor (Drexel University) and (e) streamers in
dielectric breakdown of water (INP-Greifswold)
Karl Schoenbach of Old Dominion University first coined the term “biolectrics” in 1997[1],
in a paper that examined the effects of PEFs on bacteria and aquatic nuisance species, by applying
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different electric fields at 60 ns duration. His group observed reversible damage to cellular
membranes, with ion movements induced by the fields resulting in increased membrane stress as
a potential develops across it, which has been confirmed many times since in literature[5]–[8].
Higher amplitude or longer duration electric fields create pores in the lipid bilayer of the cellular
membrane[9] that may remain open from a few microseconds to minutes[9], [10], with higher
fields inducing cell death due to excessive loss of intracellular cytoplasm and organelles. These
pores enable the exchange of macromolecules (such as drugs) and DNA[7]. This opening and
closing of the pores is determined by a threshold voltage that may result in either reversible
electropermeabilization or lysis (complete membrane breakdown due to osmotic factors in this
case) depending on the size of the cell and other membrane properties characteristic of that cell
line. If we consider the cell as a circuit, as shown in Fig. 2, we may basically consider this
phenomena in terms of charging the overall capacitance of the cell with the charging time of the
cell dependent upon cell size. In conventional electroporation, with a cartoon of a typical
waveform shown in Fig. 3, one fully charges the membrane and the formation of water channels
shifts the lipids to create pores, as depicted in Fig. 4. Appropriate selection of pulse duration and
intensity causes the pores to either reseal upon removing the pulse, or undergo reversible
electroporation, or fail to reseal upon removing the pulse, or undergo irreversible electroporation.
Fig. 5 shows conceptually how molecules will traverse the membrane in the presence of pores with
the pores resealing upon removing the electric pulse.
Applying a pulse with the same energy but shorter duration (and, concomitantly, higher
voltage), as shown in the right half of Fig. 3, will not fully charge the membrane for durations
shorter than the charging time.

The resulting pores are smaller than for the conventional

electroporation pulses; however, these shorter pulses may fully charge intracellular structures, such
as the mitochondria, cytoskeleton, or endoplasmic reticulum, enabling manipulation of
intracellular function.
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Figure 2: Representation of the cell as a circuit

Figure 3: Difference between conventional electroporation pulses of micro and milli second
durations and how they differ from nanosecond pulses.
Beebe[11]–[13] demonstrated that nsPEFs can induce cell death by apoptosis or
programmed cell death. Triggering this internal cellular “suicide mechanism” causes pyknosis
(shrinking of the nucleus), DNA fragmentation and membrane expansion (stretching). A cell goes
through apoptosis when it undergoes a mutation that must be rejected by the body, by aging and
thus undergoes repeated mitosis. This mechanism prevents the buildup of necrotic (dead) tissue
and toxic chemicals that can cause inflammation and is critical to hormonal regulation and
chemical balance.
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Figure 4: Formation of pores in the lipid bilayer of cell membranes

Figure 5: Uptake of molecules by cells through resealable pores/reversible electroporation in
action.
NsPEFs can induce apoptosis by caspase activation [11]. Activating this trigger can affect
the population dynamics of the cells, affecting therapeutics. Research shows higher fields or
increased pulse duration will increase caspase activation, leading to rapid cell death. This effect
varies across cell lines, however, as nsPEFs will alter other pathways and cell functions for other
cell lines
Cancer treatments have increasingly explored a vaccine response [12] by activating a
memory effect in the dendritic immune T-cells to combat cancer [15]–[17]. This eliminates the
immune suppression capabilities of the tumor, which allows the body to respond to attack and
eliminate the tumor while preventing the growth of new tumor cells and sites. Repeatedly injecting
tumor cells into the host tissue produced no new tumors, indicating long-term vaccination.
Several researchers [6], [13], [14] detected an increase in calcium release due to the
shrinking of the endoplasmic reticulum after pyknosis, which forms the basis for activating the
apoptotic pathways through the release of caspase enzymes and the protein calreticulin. The
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calcium molecule spike depends on the pulse amplitude, similar to caspase activation. The origin
of these molecules is from both intracellular organelles and from the membrane structure itself.
Calcium can also activate platelets[18], [19], beneficial for accelerated healing, and in the design
of a platelet gel, that could be incorporated into bandages and patches to apply to and cause clotting
at the wound site.
Applying shorter duration fields of higher strengths can permeabilize membranes by
exceeding the critical voltage value of the membrane and gates, but discharging through the
membrane as a resistor instead of treating it as a capacitor, since the field is applied for a time
period that is shorter than the membrane charging time of between 60 to 80 ns [9], [20], [21].
However, as mentioned above, since the charging time constant of intracellular structures, such as
the mitochondria and the nucleus, is shorter than for the cell, nsPEFs fully charge them. This allows
for intracellular effects with minimal membrane permeabilization[22]. Research in clinical
applications has revealed the importance of the caspase activation in inducing the apoptotic
pathways[14], [20], and affecting the performance of the cells, and thus their populations. While
adherent cells are less sensitive than suspension cell lines, pulses longer than 100 ns increased the
number of cells entering the apoptotic phase[23], a crucial factor underlying the research carried
out in chapter 2.

Figure 6: Application and scaling of electric field from pulse generator to potential applied
across a cell membrane which has a thickness of less than 10 nm.
The electric pulses are transmitted to a cuvette, which converts the signal into a field
applied across its electrodes, as demonstrated in figure 6. The electric field that is applied across
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the cuvette, not the actual voltage experienced across the membrane (the membrane potential).
Movement of ions in response to the electric field, dielectric response of molecules (rotation of
molecules in response to the field applied) and the dielectric properties of membranes and the
cytoplasm/nucleoplasm of the cell (permittivity and conductivity values) all affect the resulting
membrane potential [20], [24], [25]. Molecular dynamics simulations utilized the rotation of
dipoles of water molecules orienting themselves to the applied field and crossing the lipid bilayer
to create water based nanopores. The response to ns pulses involves the coupling of the
Smoluchowski equation, which describes the “clumping” of particles and their balance with the
Nernst-Planck equation, a mass conservation equation simplified from Fick’s law of diffusion for
charged particles in media[26]. If the value exceeds the gate voltage, the voltage gated pores will
open. Higher energies will create small water channels classified as nanopores. These nanopores
can coalesce if present in a significant quantity, leading to the formation of larger pores,
independent of the voltage gated channels[27].

Figure 7: Nanoknife (Angiodynamics®) being utilized for treatment of tumor by ablation
utilizing electric fields[31], [32] (credit : URMC)
Cell permeabilization leading to electroporation was explored in the early 1970s, as a
method of introducing drugs/agents into the cells, with higher energies being utilized for ablation
[28], [29]and irreversible electroporation [30]. Figure 7 summarizes the concept of the Nanoknife
(Angiodynamics®) for treating tumors via irreversible electroporation [31], [32]. Figure 8 shows
a representation of the application of PEFs on tissue for cancer treatment.
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Figure 8: Representation of application of pulsed electric fields on skin treatment for topical
infection/basal cell carcinomas.
One of the earliest applications of nsPEFs was for preventing biofouling, the growth of
aquatic species on surfaces of ships and other machines exposed to seas, rivers or lakes which had
been treated to immobilize the hydrozoans[1].
The charging time constant of the membrane determines the voltage change across the
membrane. Rise times shorter than charging time would result in increased current and thus, field
induced within the cell, leading to electroporation. Thus, for shorter and shorter pulse times, the
membranes become unaffected by pulsing. This allows for nsPEFs with even faster rise times to
cause fields sufficient to cross the electroporation threshold.
Other studies attempted to study the membrane properties indirectly, by examining electric
pulse induced changes on the permittivity and conductivity of the cell membranes. Nanosecond
duration electric pulses affect intracellular structures with minimal membrane permeabilization
[4]. The longer the duration of the pulse, the more likely the increase in poration of the outer
membrane. A similar phenomenon arises when changing AC frequency in the MHz regime. Sub
100 ns pulses at low fields and affect inner organelles, while longer duration or energy fields affect
the outer membrane [23]. Pakhomov conducted dye uptake studies on pulsing and found the
formation of nanopores in high density[21], [33] due to failure of uptake of propidium iodide and
ethidium homodimer, while the smaller sized molecules of Yo-Pro-1 succeeded in penetrating
cells.
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The ability to control intracellular function with minimal membrane effects allows nsPEFs
to induce apoptosis. Moreover, nsPEFs also demonstrate specificity, as results vary with cell types
and even strains of a particular cell [34]. Increasing number of pulses eliminates this difference
however, and is independent of cell size and type. Similar results seen with our Jurkat cells, where
for higher energies increase of number of pulses did not have a significant impact on cell
populations, which were equally affected.
Temperature variation can also influence membrane properties, such as their mechanical
stability, which determines whether electroporation is reversible [35], with recent studies
confirming that while bulk temperature of the media may have an influence on the dielectric
properties of the cell membranes[36]. The electromagnetic fields themselves have a minimal effect
on bulk heating, but induce cell membrane temperature gradients, requiring the creation of a
thermoelectric membrane model to better understand and model these effects[37].
Applying electric pulses with duration less than 100 ns can inactivate microorganisms
because the duration is on the order of the charging times of the microorganism [38]. The risetimes
determine the high frequency components of the Fourier spectrum of the pulse. As mentioned
above, these results indicate that the high frequency components deposit electrical energy in the
cell and affect intracellular structures[39]. Additionally controlling the rise time and fall times of
these pulses are further ways to alter the Fourier transforms of these pulses and thus their
frequency[12], but further research and experimentation is needed to determine the effects on
nuclear membranes, the nucleoplasm, DNA strands and genetic material. Chapter 3 used these
pulses on stem cells to examine their effect in inducing subcellular effects, resulting in increased
proliferation of these cells.
With regards to microorganisms and the potential of nsPEFs to sterilize bacteria[1], [38],
[40] is of great interest due to the potential to affect antibiotic resistant mechanisms, which pose a
huge threat to rendering antibiotics useless in the coming decades[41].
An increase in antibiotic resistance amongst microbes, including a recent CDC report of
the discovery of a colistin (a drug of last resort) resistant strain of E coli in china in late 2015[41],
indicates a growing problem with regards to treatment in ICUs and with bacterial infections,
necessitating an urgent need for alternative treatment methods that can reduce the viability of
bacteria without depending on antibiotics.
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Costerton et. al.,[42] hypothesized that a bioelectric effect due to low current densities may
enhance antibiotic efficacy against biofilms. Pseudomonas aeruginosa was used to form biofilms
and treated with a low voltage treatment below 10 V with a constant DC exposure resulting in a
6-log reduction for 24 hours and a 7-log for 48 hours under dual treatment conditions. Even though
only using an electric field was more effective after 24 hours than an antibiotic treatment, the
viability reached the pre-treatment value after 48 hours for continuous DC exposure, which they
attribute to binding by the exopolysaccharide matrix of the biofilm. Others have attempted to
examine DC effects for currents (2A) to sterilize mesophilic bacteria for applications such as
tanning hides[43] while noticing the conductivity/ionic change within the solution due to bacterial
death. Haddad, Mah and Mussivand[44] observed that direct electric currents increased the
effectiveness of antibiotics against Staphylococcus epidermis biofilms.
Birbir et. al.,[45] applied AC currents to inactivate certain strains of antibiotic resistant
Escherichia coli in lauryl broth and various river and sea waters, with treatment times ranging
from 1 min to 30 min depending on the salinity and other dissolved impurity content of the
solutions. This was shown to be effective too, but the advantage of nsPEFs is their ability to
penetrate into cells, with a low duty cycle and timeframe shorter than the ability of the nervous
and muscular system to react.
This is the primary reason for the effectiveness of the nanosecond pulsed electric fields
(nsPEFs) compared to larger duration pulses, as a function of the duty cycle and lowered energies
applied cumulatively during a treatment has been postulated by Chalise et. al.,[46] as damaging
intracellular components, compared to higher duration (hundreds of nanoseconds) which cause
reversible electroporation and even longer duration pulses in the milli- and micro-second ranges
that cause irreversible electroporation.
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Figure 9: Simplified equipment flowchart for electric pulse generation and diagnostics.
The experiments in these studies utilized 60 ns and 300 ns pulses, which were scaled to
deliver the same energy density to the cells under treatment. Figure 10 shows the 300 ns pulse
generator used in these studies while Figure 11 shows a typical pulse waveform. Figures 12 and
13 show the pulse generator and typical waveform for delivering 60 ns pulses, respectively. The
scaling law follows what [47] outlined for pulses of the same duration. While pulse parameters
such as the number of pulses, the durations of the pulses, the amplitudes of the fields and the
frequencies can be varied, factors such as energy delivered, thermal effects and optimizing the
number of pulses in a treatment to obtain a desired effect for minimal energy delivered, while
keeping the amplitudes of the fields as low as possible. The survival of these cells scales as an
inverse of energy density [48] for a fixed pulse duration. Charging the pulse duration requires a
different scaling law, where the field intensity E is multiplied by the pulse duration, since the total
number of ions moving under the influence of the field are proportional to the energy density. This
does not apply to bipolar pulses.
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Figure 10: 300 ns Blumlein pulse generator utilized in this study

Figure 11: Pulse produced by the 300 ns pulse generator
In combination with our current antibiotic tests, this would result in sublethally injured
cells that are then susceptible to antibiotics resulting in a synergistic and increased cell death effect.
Garcia et. al. [34] noted that microsecond PEFs inactivated bacteria and that inactivation increased
in acidic environments. This supports this authors’ study noticed with reducing salinity of plated
samples in inactivating less bacteria (lower conductivity environment).
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Figure 12: Photograph of the 60 ns Blumlein pulser utilized in this study.

Figure 13: Representative pulse of the 60 ns pulse generator, where the applied electric field was
calculated from the pulse delivered (1.2 kV).
Garcia et. al. [49] evaluated the biosynthetic requirements for membranes to recover after
exposure to PEFs, realizing that proteins and peptidoglycan are not responsible for repair, but
energy and lipid synthesis was needed, indicating that the cytoplasm repair is responsible for
bacteria recovery, thus the PEFs harm bacteria by damaging the cytoplasmic membrane.
This dissertation reports results for the applications of electric pulses in three different areas.
Chapter 2 examines the impact of nsPEFs on cell population dynamics, specifically examining the
impact of cell population within one week of treatment and using a mathematical model to assess
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the targeting of quiescent or proliferating cells. Since practical treatments will likely expose
tumors to sublethal fields due to inevitable field nonuniformity, understanding the impact of
sublethal electric fields on cell population is important for optimizing treatment efficacy and
understanding potential risk of relapse. Chapter 3 shows that applying nsPEFs can induce
proliferation and differentiation of osteoblasts and myoblasts, potentially providing a way to tune
stem cells for therapy. Chapter 4 demonstrates that combining nsPEFs with various antibiotics
can synergistically inactivate both a gram positive and a gram negative bacteria, potentially paving
the way for a novel method to treat localized, antibiotic resistant infections. Concluding remarks
and future work are addressed in Chapter 5.
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2.

CELL POPULATION DYNAMICS OF CELLS EXPOSED TO
NANOSECOND PULSED ELECTRIC FIELDS

Introduction
Cancer cell populations contain proliferating, quiescent, and dead cells that drive tumor
growth and cancer metastasis based on the surrounding microenvironment [1]–[4]. Many existing
cancer treatments are highly cytotoxic and predominantly target the proliferating cells, which are
a critical aspect of cancer development [5]–[8]. One may use mathematical models of cancer cell
population dynamics to show that a simplified population comprised of proliferating and quiescent
cells will eventually die if the transition from quiescent to proliferating cells is sufficiently small
and one successfully targets the proliferating cells [3].
While illustrative of the importance of targeting proliferating cells, this mathematical
model also demonstrates the necessity of understanding and characterizing the transition of these
quiescent cells to proliferating [3]. For instance, over the past several decades, research has shown
that cancer stem cells (CSCs), which are a small subpopulation of abnormal cells that maintain
and drive tumor growth for multiple cancer types, play a major role in cancer development and
treatment efficacy [9]. CSCs may remain in dedicated niches within tumors even after treatment
and identifying and eradicating them is challenging since their metabolism may not differ
significantly from other cells and they may remain dormant, or quiescent for long periods of
time[9], [10]. In this state, CSCs exhibit great “robustness,” characterized by a long cell cycle
(thus appearing quiescent), the ability to detoxify or mediate cytotoxic agents (including pumping
out drugs), resistance to oxidative stress, and responsiveness to DNA damage[5], [10]. Cancer
dormancy presents a particularly challenging problem since this may result in cancer recurrence
long after initial cancer treatments since the transition to quiescence makes these cells less
susceptible to treatments targeting proliferating cells [11]–[14]. Although the dormant cells may
be small in number, making them virtually undetectable, they may eventually grow to sufficient
size or number due to a permissive immune system and eventually recruit blood vessels through
an angiogenic switch [11].
Thus, effective cancer treatments must simultaneously eradicate the proliferating cells
responsible for tumor growth and cancer spread while additionally impacting the quiescent, or
dormant, cells that may eventually induce a relapse. Since the dormancy of CSCs makes targeting
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them with traditional treatments challenging, one alternative strategy involves targeting their
quiescence[10]. For instance, chronic myeloid leukemia (CML) is often treated with imatinib,
which targets the oncogenic fusion protein produced by the Philadelphia chromosome[15];
however, imatinib strongly inhibited differentiated leukemia cells, while not depleting the stem
cells [16]. Ablating Fbw7, an antimetastatic protein, can successfully make imatinib-resistant
CML cells sensitive to the drug again [10]. Thus, one may control cell cycle as a means to
effectively treat cancer.
For localized cancers, one may alternatively explore alternative physical means for
treatment. One method that has evolved over the past several decades uses electric pulses (EPs).
EPs with sufficiently high electric field and pulse duration may charge the plasma membrane
above a certain threshold (typically on the order of a few hundred millivolts to a volt) to create
membrane pores in the phenomenon of electroporation [17]. For sufficient pore size and quantity,
the plasma membrane may fail to recover after the EP, resulting in cell lysis, or death [18]. This
technique is well established for liquid decontamination [19]. If the pore sizes remain below a
certain threshold, the plasma membrane may recover, or undergo reversible electroporation [18].
Reversible electroporation is often used for gene transfection [20].
Conventional electroporation uses EPs with durations on the orders of microseconds to
milliseconds and electric fields on the order of ~100V/cm to 10 kV/cm. These EPs have been used
in cancer treatment for several decades in electrochemotherapy, where they permeabilize tumors
to facilitate chemotherapeutic transport into the tumor [21]. Clinical studies in Europe have
explored electrochemotherapy for multiple targets, including metastatic malignant melanoma,
basal cell carcinoma, and head and neck cancers [22]–[24]. Irreversible electroporation (IRE), in
which EP eradicate the tumor without requiring additional drugs, has also recently gained traction
as a treatment modality [25]–[27]. IRE has demonstrated promising success for treating canine
glioma [28], pancreatic cancer [29], and liver cancer [30] in vivo and ovarian cancer in phantoms
[31]. Although IRE may induce apoptosis, or programmed cell death, electroporation tends to
predominantly target the membrane, meaning that necrosis is possible. While either apoptosis or
necrosis may eradicate a tumor or cancer cells, apoptosis results in less swelling and adverse side
effects in treatment.
Nanosecond EPs (NSEPs), with durations from 10-300 ns and electric fields from ~30
kV/cm to 300 kV/cm, may also interact with biological cells [32]. While NSEPs may interact with
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the membrane to create nanopores [33], they may also interact with the intracellular structures,
such as the mitochondria, since they will fully charge these smaller structures before the plasma
membrane [34]. NSEPs have effectively induced apoptosis in melanomas [35] and have since
been used for basal cell carcinoma (BCC) therapy [36] and breast cancer treatment [37] in humans.
NSEPs cause pyknosis of the nuceli in the BCC while also inducing the endoplasmic reticulum to
release the protein calreticuluin [36]. When calreticulin is trapped in the lipid bilayer, it signals the
dendritic T-cells that the apoptotic pathway has been opened [36].
The importance and utility of different EPs for treating cancer and the importance of
targeting populations of both proliferating and quiescent cells for an effective treatment motivates
better understanding the impact of EPs on cancer cell population dynamics. This is particularly
critical since EPs may selectively target different cells [38] and lower strength electric fields may
actually increase cell growth [39]. In fact, even for tumor treatment, even though EPs may initially
destroy a small fraction of the cancer cell population, the total cell population may actually increase
over time[40].
Thus, this chapter explores the impact of various numbers and intensities of 60 ns and 300
ns EPs on E6 Jurkat cells, an acute T-cell leukemia suspension cell line found in the peripheral
blood of tissues as a result of acute T-cell leukemia. The experiments will elucidate the potential
implications of NSEPs on long-term cell population dynamics while applying a simple
mathematical model considering cells as either quiescent or proliferating to explore the potential
target of the NSEPs. Section 2.2 outlines the equipment, procedure, and mathematical model used
in this study, and then summarize the experimental results and the parameters that arise from fitting
the model. Section 2.3 discusses the implications of the results and make concluding remarks.

Figure 14: A block diagram representation of the proposed mathematical model ([50], [Garner
cell prolifer paper]) for cancer cell population dynamics, where x(t) and y(t) represent the time-
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dependent populations of proliferating and quiescent cells, respectively, b describes the cell
birth rate, d describes the cell death rate, and P(x,y) and Q(x,y) describe the transition rate from
proliferating to quiescent and quiescent to proliferating states, respectively.
Materials And Methods
2.2.1

Pulsed Power Equipment
This study utilized assessed 300 ns and 60 ns electric pulses (EPs). The 300 ns Blumlein

type pulse generator was charged by twenty-four 40 kV capacitors and twenty-four 600 nH
inductors that terminate into an 11 Ω load, which we replace with the 2 mm gap cuvette (Biorad®)
containing the cell suspension. The 60 ns pulse generator consisted of two parallel Blumlein stages
consisting of RG-213 transmission lines, which act as capacitors, to reduce impedance. Since 1 m
of cable takes 5 ns to discharge, each side of the Blumlein has 12 m of cable terminating in a 20
Ohm load. We used the same cuvettes across all experiments to ensure consistency of the
treatment conditions. We triggered the pulse generators using a brass spark gap switch and
powered using a Glassman series EJ power supply.
We used a high voltage probe of 1000:1 attenuation (LeCroy 100 MHz, 20 kV model
PPE20KV) connected to a Waverunner 6 Zi Oscilloscope (both manufactured by TeleDyne
LeCroy®) to measure the applied voltage. The measured signal represents the voltage applied
across the cuvette when the switch sparks, triggering the pulse. We report the applied electric field
as E = V/d, where V is the peak voltage of the applied pulse and d is the gap distance. As shown
in Fig. X(a), the applied 300 ns appear trapezoidal with ~ 330 ns duration at the peak voltage, 50
ns rise- and fall-times, and a pulse repetition frequency of 1 Hz. Fig. X(b) shows that the 60 ns
pulse generator gives a waveform with a full width half max (FWHM) of ~60 ns with some
oscillation afterward due to slight mismatching across the load.
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Figure 15: Representative waveforms for electric pulses applied for treatment (a) 300 ns and (b)
60 ns
2.2.2

Cell Suspension Preparation.
Cells were cultured in RPMI 1640 (Gibco™) containing 1% antibiotics (penicillin-

streptomycin) and 10% fetal bovine serum (FBS) and 5 mM L-Glutamine in 10 cm cell culture
treated Petri dishes (VWR ®) in a 5% CO2 incubator at 37°C. The 0.5% salinity of the growth
media provides the ideal conductivity for matching the samples in the cuvettes to the 11 Ω output
impedance of the pulse generator. This experiment used Jurkat, Clone E6-1 cells (ATCC ®), an
immortalized acute T-cell leukemia suspension cell line. The cells were preserved in liquid
nitrogen and thawed in a 37°C water bath, centrifuged to remove the supernatant and then
suspended in RPMI-1640 growth media. The cells were passaged upon reaching 90% confluency,
between 60 and 72 hours (approximately 3×106 cells/ml), with fresh media added for every third
passage by centrifuging, draining supernatant, and resuspending the pellet in fresh media to drain
away detritus, with each passage plated at 5×105 cells/ml. To maximize consistency between
experiments, samples were tested between the eighth and twenty-fifth passages.
2.2.3

Electric Pulse Treatment Protocol
Cells were placed in the 2 mm cuvettes and pulsed using clinically relevant parameters [14]

to examine the effects of electric pulses [4] on cell population dynamics[51]. Cuvettes were filled
with 410 µL of the sample diluted to a concentration of 2×106 cells/ml, which we counted using a
Countess II ® Automated Cell counter. We manually counted the initial trials using a
hemocytometer; however, subsequent experiments used the Countess to maximize the consistency
of the counts and minimizing the time between counts. The cuvettes were pulsed at a repetition
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rate of 1 Hz to eliminate the possibility of frequency effects[52] such as desensitization of the
membrane while also minimizing the potential for both sample heating and localized temperature
gradients, which may induce non-electrical membrane effects[24]. For the 300 ns EPs, we applied
trains of ten, thirty and fifty electric pulses at 5 kV/cm, 20 kV/cm and 30 kV/cm to assess the
impact of applied electric field. We also studied the impact of applied pulse energy by applying
360, 1080 and 1800 60 ns electric pulses at 5 kV/cm such that the applied energy, determined by
U = NE2τ was the same as 5 kV/cm. We counted the cells immediately post pulsing by using a 50%
by volume Trypan Blue mix with the disposable slides for the Countess to determine the immediate
kill – off due to pulsing. Each experiment included three samples with different parameters and a
control, yielding three replicates of each of the four conditions in the twelve wells.
2.2.4

Plating/Counting.
Counts were taken every twelve hours with samples spun down and media exchanged every

twenty-four hours. Experiments were run in the evening of the first day and then plated in six-well
plates (VWR ®), where 400 µL of the sample media was mixed with 1.6 mL of growth media,
totaling 2 mL/well. Each set of parameters was tested in triplicate, with three cuvettes pulsed under
identical conditions. We extracted 10 µL of each sample every twelve hours into an individual 0.5
mL Eppendorf tube and mixed with 10 µL of Trypan-blue to count the sample in the Countess.
We report the results as the average of three samples with the standard deviation. When a sample
attains 2×106 cells/mL, it is spun down after that count, resuspended in fresh media using 2 mL
Eppendorf tubes, and then re-plated. This prevents issues that arise with cell viability that arose
at these higher volume loadings that we observed in preliminary experiments.

Mathematical Modeling of Cell Population Dynamics
Assuming that the cancer cell population consists of proliferating and quiescent (resting)
cells, the cells can lose their ability to divide under certain conditions and, therefore, transit from
the proliferating to the resting state, resting cells can either return to the proliferating state or die,
and that cell death is irreversible, one can write the growth kinetics by [51], [53]

 ′   
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(2)
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where x(t) and y(t) are the number of proliferating and quiescent cells at time t, respectively, b and
d represent the rate of cell division of proliferating cells and rate of cell death of quiescent cells,
respectively, and Q(x,y) and P(x,y) describe the intensity of cell transition from the quiescent to
proliferating state and vice versa (day-1), respectively, and are given by

,   
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and


(4)
.
1   
which references [51], [53] describe and justify, with initial proliferation rates for cells in this stage
,  

described in [54].
Garner, et al. nondimensionalized the system of equations given by (1) through (4) to assess
when Q(x,y) may be neglected [51]. The current study assumes Q(x,y) ~ 0 and then fits the
remaining constants a, b, c, and d. Combining (1) and (2) with (3) yields
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(5)
(6)

Unlike Solyanik’s [53] tests, our samples were fed with additional nutrients upon attaining a
specific cell concentration. This additional feeding may impact the rate of transition from
quiescent to proliferating, making Q(x,y) nonzero. Thus, we will briefly examine the implications
of nonzero Q(x,y) on the fit and the impact of EPs on the treated cells in Sections 2.3 and 2.4,
respectively.
After entering the initial ratio of proliferating and quiescent cells, we solve the resulting
coupled ordinary differential equations (ODEs) in (5) and (6) from 0 to ten days after treatment at
intervals of 0.1 days (2.4 hours) and then obtain the total number of cells as z(t) = x(t) + y(t). This
allows us to determine a, b, c and d by performing a least squares fit of the calculated z(t) to the
measured cell counts. The first trial used a manual hemocytometer and was replicated with an
automated counting machine. These experiments applied 300 ns pulses with low electric fields
(from a treatment standpoint) based on preliminary experiments indicating that a single EP induced
no noticeable death immediately post-pulsing while five EPs at higher fields induced
approximately 50%. This motivated the second set of trials, which tested the effects of one, three,
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and ten EPs at 3 kV/cm, 5 kV/cm and 20 kV/cm respectively), with the same number of pulses
applied for 60 ns with identical conditions for 60 ns. The third set of trials applied one, five, and
ten 300 ns EPs with more clinically relevant fields of 5 kV/cm, 20 kV/cm, and 30 kV/cm, which
demonstrated the existence of a threshold electric field above which the cells could not recover.
This led to a fourth trial where we applied 10, 30 and 50 300 ns electric pulses at 5 kV/cm (lowfield), 20 kV/cm (medium field) and 30 kV/cm (high field) on the 300 ns pulse generator, and the
conditions of the highest field on the 30 kV/cm, 300 ns were energy matched to a 5 kV/cm field
on the 60 ns pulse generator, resulting in an increased number of pulses, and similar results in the
discovery of a threshold.
Table 1 lists the various 300 ns electric pulses delivered to Jurkat cell supsensions.
Table 1: Pulses applied to Jurkat cells
Field (kV/cm)

# of
Pulses
10

30
(High Field)

30
50

20
(Medium
Field)

10
30
50
10

5
(Low Field)

30
50

This fourth trial consisted of three experimental parameters and a control plated in six-well
plates and counted for a maximum of 168 hours to obtain growth curves. Figures 1 and 2 below
show the resulting cell counts The figures below contain the data for the different figures, starting
at the lowest field of 5 kV/cm in figure 1, 20 kV/cm in figure 2 and 30 kV/cm in figure 3.
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Figure 16: E6 Jurkat cell population as a function of time for untreated control cells and cells
exposed to 10, 30 and 50 300 ns electric pulses at (a) 5 kV/cm, (b) 20 kV/cm, (c) 30 kV/cm, and
(d) 380, 1080, and 1800 60 ns, 5 kV/cm electric pulses. The lines represent the fit of the model
given by equations (5) and (6)
Table 2: The number of 60 ns, 5 kV/cm electric pulses selected to match the energy of the 30
kV/cm, 300 ns electric pulses from Table 1.
Field (kV/cm)

# of
Pulses
360

5

1080
1800

We next performed a least squares fit of the experimental data to the model from (5) and
(6) to obtain a, b, c, and d. We considered ten iterations to ensure that these parameters were
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insensitive to the selected initial fitting parameters to ensure that the obtained values were not
numerical artifacts.
It is critical to select the appropriate ratio of proliferating to quiescent cells to appropriately
fit the data; however, the exact value of this ratio can vary quite significantly depending on cell
morphology and extracellular conditions with various values in the literature for Jurkat cells.
Solyanik, et al. [53] that the fraction of proliferating to quiescent cells was initially 70%
proliferating and 30% quiescent. We examined the effect of various proportions of proliferating
and quiescent cells starting at 60/40[55], 70/30[53] and 84/16[54] and determined that 84%
proliferating and 16% quiescent gave the best fit to experimental conditions. Table 3 summarizes
the resulting fitting parameters.
Fig 2 shows that the fitting parameters approximate the population counts of the cells, with
the control and the cells treated with 5 kV/cm growing from less than 106 cells to 109 cells in eight
days, while the populations of the cells treated with either 20 kV/cm or 30 kV/cm electric pulses
stabilized between 1.50×105 and 2.0×105 cells per mL (in a 2 mL well) for the last four days of the
experiment. Similar behavior arose for the energy matched 5 kV/cm, 60 ns electric pulses,
implying the minimum threshold is not dependent solely on energy (as the energy density of the
60 ns was matched to the 300 ns). This result may however be the result of the membrane charging
time of the cell membrane being between 60 and 80 ns, resulting in the field shorting the membrane
and penetrating the membrane[9], [20], [21], exerting it’s influence on intracellular organelles,
which would imply that the inactivation or effect on cell proliferation is not due to pulse treatments
causing electroporation and affecting the outer membrane, but some other intracellular organelle,
affecting its recovery.
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Table 3: Values for fitting parameters obtained from fitting experimental data to the model
developed in Refs. [53] and [51] with the initial cell population assumed to consist of 84%
proliferating cells and 16% quiescent cells [54].
Electric
Field
(kV/cm)

5

20

30

5

Pulse
Duration
(ns)

300

300

300

60

Number of
Pulses

a

b

c

d

r

Control (0)

0.236656

0.746064

0.889384

1.00x10-5

1.34E x10-5

10

1.28797

0.707249

0.536838

5.99Ex10-5

8.46E x10-5

30

34.57845

0.624243

0.053468

2.49Ex10-2

3.98E x10-2

50

100

0.530494

0.034865

0.9999

1.88

Control (0)

1.00x10-5

0.677339

0.914898

1.00x10-5

1.48E x10-5

10

45.44068

0.178465

0.047728

0.540

3.03

30

99.98675

0.096946

0.417262

0.844

8.71

50

25.08533

0.132953

1.509496

0.239502

1.80

Control (0)

0.236775

0.746057

0.889296

1.00E x10-5

1.34E x10-5

10

52.12511

0.231014

1.03291

1.00

4.33

30

100

0.359622

1.082588

1.00

2.78

50

99.98433

0.179032

0.247531

0.9999

5.59

Control (0)

0.653169

0.647552

0.553915

360

99.17804

0.151731

0.117041

1080

100

1800

99.89979

1.00

x10-5

0.225851

100
0.462332

2.47

x10-2

1.00
8.00

x10-2

0.412765

3.82 x10-2
6.59
8.00 x10-3
1.83

Results And Discussion
Initial experiments revealed the need to apply more electric pulses to determine the
threshold for arresting cell population growth. Despite the controls doubling every 24-36 hours,
applying 10, 30, or 50 300 ns electric pulses arrested Jurkat cell population growth, as shown in
figures 3 and 4. A similar minimum threshold arose when matching 5 kV/cm, 60 ns electric pulses
to the energy of the 5 kV/cm, 300 ns electric pulses by fixing the energy density with a fixed
extracellular conductivity, or U = NE2τ, where N is the number of pulses, and τ is the pulse duration
as seen in [47]. Figure 5 shows that applying the resulting additional 60 ns electric pulses to achieve
the same energy delivered as the train of 300 ns electric pulses results in the same arrested cell
population growth.

Interestingly, as one reduces the pulse duration, one anticipates less

conventional electroporation, particularly since 60 ns is much shorter than the typical membrane
charging time while 300 ns is approximately on that order of magnitude. Although determining
the exact mechanism of cell death is beyond the scope of the current study, a few words are in
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order. Early studies on nanosecond EP effects indicated that these EPs could induce intracellular
effects, such as releasing intracellular calcium stores and inducing apoptosis, while not sufficiently
charge the cell membrane to create the larger pores characteristic of electroporation that would
enable the transport of conventional dyes used to assess membrane integrity, such as ethidium
homodimer and trypan blue. Later studies using the dye YO-PRO-1 and dielectric spectroscopy
demonstrated that membrane pores (or, at least, membrane permeabilization) occurred at a
sufficient level to permit the transport of ions. Such ion transport has been leveraged for
facilitating calcium transport in platelet activation, for instance. In this cell population study, while
we would not anticipate a few 60 ns EPs to create conventional electroporation, computational
assessments of membrane pore formation and experiments have demonstrated that such EPs create
many smaller nanopores in a phenomenon dubbed “supraelectroporation.” Thus, it is possible that
applying so many additional 60 ns EPs to energy match to the 300 ns EPs causes some of the
resulting nanopores to ultimately coalesce, resulting in something much like conventional
electroporation even though the pulse duration is shorter than the membrane charging time. Future
experimental and theoretical studies will elucidate this mechanism to determine whether the cell
death mechanism is apoptosis (intracellular) or necrosis (membrane driven).
The static nature of the cells affected by the treatments of 20 kV/cm 30 kV/cm pulses of
300 ns duration and 5 kV/cm pulses of 60 ns duration is similar to healthy cell lines that reach a
plateau after growing, where the cells are constrained by space and nutrient concentration and the
overall cell death and cell birth balance to achieve a steady state in cell population. This is the
point where population decay begins to take place, as the increased proliferation of cells also
causes a corresponding increase in quiescent cells. As these quiescent phase cells consume a larger
share of the nutrients (a), the proliferation rate of the proliferating cells (b) begins to decline,
further increasing the quiescent cell population. This also ensures the transition rate of quiescent
to proliferating cells, Q(x,y) remains low, while the death rate of quiescent cells increases due to
reduced nutrients available, causing the population to eventually decline and die out. The constant
supply of abundant nutrients, however, overcomes this in all cases except for the control, which
reaches the limits of the nutrients and cells the wells can hold at 4x106 cells per well. The data
does show that the remaining treatments of the low field of 5 kV/cm at 300 ns pulse duration were
steadily proliferating, likely to reach a level of 4x106 cells within 24-36 hours. The cell populations
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in the remaining treatments did not recover, even when resuspending the cell in fresh media, with
no significant difference in population with respect to the control, as seen in figure 6.

Figure 5: Static behavior of cells seen post pulsing on the high electric field of 30 kV/cm for 300
nanosecond pulse treatments with modeled trendlines;
Figure 5 does not exhibit a standard logistical “S-curve.” Instead, the electric pulse train
arrests the cell population growth such that it remains approximately constant rather than growing
and leveling out as the control does. This indicates that the damages to the cells to the point that
one may tune the electric pulse protocol (pulse duration, number of pulses, and electric field) to
reach this condition of constant population growth. This is a particularly critical concept when
one considers practical in vivo tumor treatment. While one typically endeavors to apply as uniform
of a field as possible, an actual tumor will tend to be nonuniform. Even an avascular tumor will
have different regions, such as the proliferating rim, quiescent region, and necrotic core, which
may behave differently when exposed to an electric pulse train due to dielectric properties or
general sensitive to the electric fields. The results above indicate that a range of pulse parameters
exist such that cells exposed to electric fields lower than the “arresting field” exhibited above will
continue to undergo net population growth rather than undergoing subsequent cell death, hindering
the treatment efficacy of the electric pulse protocol. Future studies characterizing these fields for
in vitro or in vivo tumors will elucidate these thresholds and help guide electric pulse protocols
and electrode placement to optimize potential therapy.
population growth
Mathematically, the plateau for arrested growth resembles the final steady state behavior
expected in the traditional logistic S-curve except at a lower level. Mathematically, the steady
state number of proliferating and quiescent cells are given by [Garner, et al 2006] and implicit
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within the theoretical development of equations (5) and (6) is that the initial growth of the cell
population should be exponential. In the case of the arrested cell growth, it is difficult to definitely
call the growth exponential. In principle, one could relate the final steady state value of the arrested
cell population to the number of pulses for a fixed electric field and pulse duration and determine
the variation of cell population to field strength.
One other point is that while previous studies demonstrate that a large change in Q(x,y) is
required before it has a noticeable impact on cell population compared to P(x,y), that does not
mean that stimulating the cells in some manner will not change Q(x,y). Physically, one may
anticipate that applying electric pulses to biological cells may either adversely impact their ability
to divide or stimulate them to divide more. If stimulated, this would naturally lead to increased p.
It may also result in some quiescent cells being induced to become proliferating. More likely is
that proliferating cells are forced to become quiescent due to damage. For example, as mentioned
in Section 2.1, cancer stem cells may remain dormant for long periods of time. Moreover, since
the mathematical model above assumes that proliferating cells must become quiescent (in other
words, they must at least stop dividing, no matter how briefly) before dying, it seems likely that
electric pulses will result in an increased P(x,y) with no noticeable change in Q(x,y).

Conclusions
Experiments were conducted to measure the effects of nanosecond pulsed electric fields on
the population dynamics of cancer cells. Tests were conducted for three distinct electric field
strengths of 5 kV/cm, 20 kV/cm and 30 kV/cm for 10, 30 and 50 pulses each to find a threshold
beyond which recovery was severely affected, is initial tests conducted for one, five, and ten pulses
hinted at the possibility of such a region. We also ran a tests to determine the effects of 60 ns pulses
for the low field of 5 kV/cm, matching the same energy density as the low field treatment for 300
ns. These effects were similar to the steady state behavior witnessed for the 20 and 30 kV/cm
treatments of the 300 ns treatment. We utilized a mathematical model to determine the mechanics
at work, revealing that the steady state populations had a higher death rate of quiescent cells than
birth rate of proliferating cells r, which being higher than the consumption rate of nutrients by
quiescent cells a, would imply an increase in proliferating cells over time, which was verified by
experimental data, thereby suggesting a decrease in transition rate of cells from proliferating to
quiescent, or more likely, an increased transition rate of surviving cells from a quiescent to a
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proliferating phase. It could also imply the cells are recovering from damage caused due to the
treatment and are exhibiting increased mitotic length.

Future work
This work was constantly revised due to experimental refinements to minimize variation and
human factors involved in assessing the populations, thereby reducing the error in the population
count. It was also expanded to include clinically relevant parameters[56], and when further studies
revealed a threshold below which there was no recovery, it was expanded to study that region.
Future work will include the extraction of parameters from these curves to use in the model
described above[50], to determine the properties of the different functions and thus, giving us an
understanding of how growth is affected and changed.
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3.

ELECTRIC PULSE MANIPULATION OF STEM CELL
PROLIFERATION AND DIFFERENTIATION

Introduction.
The slow proliferation of muscle and bone stem cells until they differentiate is a major
obstacle in applying stem cell therapies for muscular and bone regeneration in the clinic[57], [58].
Furthermore, the ability to induce differentiation may benefit certain applications, such as bone
healing. The utilization of electric fields for treatment and regeneration is increasingly growing
popular as an alternative to utilizing drugs or gene therapy, as a practical and quicker modality
[59]–[61]. Current research into electric field stimulation of stem cells is limited. A single 2.5
V/cm electric pulse (EP) of 90 s duration altered cardiomyocyte differentiation by increasing the
number of beating foci while applying a single 5.0 V/cm EP additionally increased intracellular
reactive oxygen species[62], [63]. One may also control differentiation by modifying the
membrane potentials[64], [65] or electrically inducing cytoskeletal stresses that facilitate
manipulation of osteoblasts and mesenchymal stem cells[66], which was previously possible only
by using chemicals[67] or proteins[68]. These membrane potentials control voltage gated
channels[69] and the influx of ions, which plays a significant role in determining the differentiation
of embryonic stem cells[70]. Feng, et al. [71] stimulated neural stem cells with electrical currents
to mobilize them within the brain to induce differentiation. While effective, these treatments often
require relatively long application times and the mechanisms may be challenging to apply
consistently since the physical interactions may conflict with long-term physiological mechanisms
at similar voltages and currents. Despite the lack of studies examining the effect of these electric
fields on osseointegration, recent studies have found a beneficial effect of electrical stimulation on
bone growth. Gittens et. al [60] examined electrical stimulation of titanium surfaces, utilized in
implants, for clinically promoting bone regeneration for fractures by using fields lower than 500
mV on osteoblasts to increase differentiation. Griffin et. al [61] observed increased differentiation
and mineralization and collagen production of osteoblast-like cells in vitro under the application
of a degenerate sine-wave and capacitively coupled stimulation for 4 hours. Adipose-derived
mesenchymal stem cells in conductive scaffolds saw increased growth under electrical stimulation
due to the roles of voltage-gated channels of calcium, sodium and potassium[72].
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Nanosecond electric pulses (NSEPs) can overcome these challenges by applying decisively
non-physiological parameters with electric fields of 30-300 kV/cm and pulse durations of 10-300
ns to induce various physical mechanisms, such as plasma membrane nanoporation, ion transport,
and intracellular structure manipulation[2]. While further research is needed to determine their
influence on gene expressions and growth factors, the ability to provide both mechanical and
electrical stresses[73] needs appropriate tuning of intense EP parameters may facilitate adequate
microenvironment control to manipulate stem cell function.
Adult skeletal muscle demonstrates an efficient regenerative capacity in response to
physiological stimulus, such as intense exercise and muscle injury, by activating resident stem
cells (satellite cells) in a mediated myogenic program. These cells remain quiescent between the
basal lamina and the plasma membrane of the myofibers until activated by regenerative signals.
Once stimulated, these satellite cells commit to myogenic precursor cells and undergo multiple
rounds of divisions, differentiation and fusion to form new multinucleated myofibers, which is
critical for postnatal maintenance of skeletal muscle and muscle repair. Aging muscles exhibit
impaired regenerative ability partly due to a loss of population and increase defects in satellite
cells.
This study experimentally assessed the impact of pulse duration, field intensity, and number
of pulses on muscle stem cell proliferation and differentiation. Schoenbach, et al. reported that
applying more pulses induces multiple subcellular effects such as the release of cytoplasm due to
electroporation, the release of calreticulin from the endoplasmic reticulum, and pyknosis [14].
Further increasing the number of pulses induced significant membrane damage and cell death. The
lower number of pulses applied in this study examines the potential of using NSEPs to stimulate
stem cells, as in NSEP activation of platelets. The potential implications of these results to
regenerative healing and tissue repair will be discussed.
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Figure 17: Brightfield microscope images of mouse primary myoblast cultured from neo-natal
mice (left) and their differentiation into myotubes (right).

Figure 18: Activation of myoblast cells in myofibers upon injury activation. (Source: Nat Clin
Pract Cardiovasc Med © 2005 Nature Publishing Group)
Materials And Methodology
3.2.1

Isolation and culture of Primary myoblasts
Primary myoblasts were isolated from hind limb skeletal muscle of 4-week mice as described

above [74] (PMID: 27880908). Briefly, muscles were minced and digested in type B collagenase
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and dispase II mixture (Roche). Digested cells were harvested and cultured in growth media, F-10
Ham’s medium (Thermo Fisher Scientific) supplemented with 20% fetal bovine serum (FBS,
Atlanta), 4 ng/ml basic fibroblast growth factor (Thermo Fisher Scientific) and 1% penicillinstreptomycin (Thermo Fisher Scientific) on collagen-coated dishes. Primary myoblasts were
isolated and purified after pre-plating two to three times. Primary myoblasts were then induced to
differentiate by growing in Dulbecco's Modified Eagle Medium (DMEM, Sigma,) supplemented
with 2% horse serum (Sigma) for at least two days.
3.2.2

Culture of primary human osteoblasts
Primary human osteoblasts obtained from vertebrae (Sciencell ®) were cultured in

Dulbecco’s modified eagle medium DMEM nutrient mixture F-12 (Ham) supplemented with 10%
FBS with 1% L-Glutamine + 1% Penicillin-streptomycin antibiotic in tissue culture grade flasks.
Cells were removed from the adhered surface and concentrated to 2x106 cells/ml prior to pulsing
in a 2 mm gap cuvette. These were then plated in 96 well plates to take counts 4 hours, 24 hours
and 48 hours after the experiment using an MTT stain, followed by plating cells at different
concentrations of 10,000, 25,000 and 50,000 cells/well in a 24 well plate for immunostaining prior
to fluorescence experiments.
3.2.3

Nanosecond electric pulsing
To maintain consistent stem cell regenerative capacity, we used myoblasts between the

second and eighth passage for all experiments. Myoblasts were cultured in 10 cm dishes until
achieving 80% confluency. Similarly, osteoblasts were passaged for pulsing upon reaching 80%
confluency. Both samples were diluted to a concentration of 2x106 cells/ml to which nsPEFs were
applied in standard electroporation cuvettes (Dot Scientific ®) using a 300 ns Blumlein (fixed)
pulse generator consisting of 24 capacitors and inductors arranged as a standard Blumlein circuit
design, as shown in Figure 11. The pulse generator produced square electric pulses of 300 ns
duration at the peak with rise and fall times of approximately 30 ns powered by an EJ series
Glassman ® high voltage 600 W DC power supply, and activated with a spark gap switch. Each
treatment exposed the samples to five pulses at a repetition frequency of 1 Hz. The resistance of
the samples in the cuvettes matched the pulse generator’s impedance to prevent pulse reflection.
All experiments used 2 mm cuvettes to ensure consistency between tests. The applied voltage was
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measured across the cuvette using a LeCroy PPE 20 kV high voltage probe with a 1000:1
attenuation that fed into a TeleDyne LeCroy ® Waverunner 6 Zi Oscilloscope capable of
measuring up to 4 GHz. Figure 11b shows a typical measured waveform. The reported electric
field across the parallel plates is given by E = V/d, where V is the peak voltage of the applied pulse
in kV and d is the gap distance in cm.
3.2.4

Post-Pulsing plating
Immediately after treating the myoblasts with five pulses, we used a hemocytometer to

determine the number of surviving cells and the viability, to ensure the plating of the same number
of live cells in each well. This required diluting the samples, accounting for cell death to ensure
the plating of 20,000 live cells per well. Three wells each were used for MTT assays at 24 and 48
hours after pulsing in 96 well plates.
3.2.5

Cell proliferation assay
Cell proliferation was assessed by using the methyl thiazolyl tetrazolium (MTT) Cell

proliferation assay kit from ATCC (ATCC 30-1010K). Experiments were performed in pulsed
cells at 0, 24, 48 h with the addition of 10 µl 5 mg/ml MTT to each well of the 96 well plates.
Media were drained 4 h after incubation at 37oC for the initial (0 hr) count, to allow adherence to
the dish surface. Purple formazan dyes were dissolved in 100 µl DMSO in each well and
absorbance was measured at 570 nm for the myoblast experiments.
3.2.6

Immunofluoresence
Pulsed cells were seeded in 24 well plates at a density of 300,000/ well. After 48 h, the cell

were cultured in growth media or differentiation media for 72 h. The media was then removed and
the cells were fixed in paraformaldehyde (PFA) for 5 min and then incubated in 100 mM glycine
for 15 min. Cells were then permeabilized and in blocking buffer that contained 5% goat serum,
2% bovine serum albumin, 0.2% Triton X-100 and 0.1% sodium azide in PBS for 1 h. Myosin
heavy chain protein was used as the maturation marker of myoblasts. The primary antibody MF20
(R&D Systems ®, #MAB4470, mouse) was added to the blocking buffer in a 1:30 dilution and
applied to cells overnight in 4° C. Cells were then incubated in an anti-mouse IgG2b 568
(Invitrogen) secondary antibody for 1 h and cell nuclei were co-stained with 1µM DAPI.
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Fluorescent images were captured with a CoolSnap HQ charge coupled-device camera
(Photometrics) by using a Leica DM6000 microscope to take four to six images per well.

Results.
Figure 19a displays increased cell populations for 5 pulses at 300 ns for low field strengths
of 2.5 kV/cm, compared to the control for 24 and 48 hours. Figure 19b shows that the number of
cells that survive treatment decreases for increased field strengths. While NSEPs have been
utilized for treatment before, such as microorganism inactivation[38], [46] and activation of
apoptotic pathways in melanomas[14], the intent of this study was to examine the effect of low
fields on stem cell stimulation[62], [70], [71]. While applying nsPEFs allows for a lower duty
cycle and application of higher field strengths[3], the initial tests in this study revealed that
applying relatively few pulses with low field strengths from 2.5 kV/cm to 5 kV/cm, induced cell
stimulation and accelerated growth, as shown in figures 19(a), 20 and 21 for both myoblasts and
osteoblasts.
As seen in table 4, the increasing field strengths are responsible for the death of more and
more cells for just 5 pulses, confirming what was suspected by Kolb et. al. [75], who examined
the effects of increased number of pulses causing cell death but hypothesized that by applying the
scaling laws of [47], an increased death would be seen for increased field strengths.
Without induction of differentiation by reducing the serum in the media, myoblasts started
to differentiate autonomously, due to the high density of cells caused by increased proliferation,
which would deprive nutrients. The maturation of myoblasts can be seen under immunostaining,
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with the red marking the actin fibres that begin to differentiate into muscle strands between cells,
and blue marking the nuclei of the cells.

(a)

(b)

Figure 19: (a) Myoblast population determined by MTT assays 24 and 48 hours after electric
pulse treatment. (b) Cell count taken immediately after treatment in order to plate an identical
number of cells in each well.
Similarly, osteoblast concentrations were set to 2×106 cells/ml prior to pulsing. For the
untreated control sample, 10 µL of this sample corresponds to 20,000 cells/well. This same volume
of fluid was then plated for all samples. The initial population count was taken using an automated
cell counter (Countess ®). MTT assays at 4 hours, 24 hours and 48 hours respectively were
conducted with 3 wells for each sample (n=3). The growth curves measured from the MTT assay
are shown as percentage of growth over 24 and 48 hour periods over the unpulsed Control sample
and are presented below, showing a similar result to the myoblast results. 3 identical tests were run
and presented below.
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Figure 20: Osteoblast proliferation data recorded for 0, 24 and 48 hours demonstrating increased
proliferation for Trial 1 for fields from 2.5 kV/cm to 10 kV/cm.

Figure 21: Osteoblast proliferation data recorded for 0, 24 and 48 hours demonstrating increased
proliferation for Trial 2 for fields from 2.5 kV/cm and 5 kV/cm.
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Figure 22: Osteoblast proliferation data recorded for 0, 24 and 48 hours demonstrating increased
proliferation for Trial 3 for fields from 1.5 kV/cm to 5 kV/cm.
Table 4: Population counts (in millions/ml) of samples pulsed in Phase 1 showing kill off with
increasing field treatment for Myoblast cells.
Population count (in millions of cells / ml)

Cumulative

Electric Field

Standard
Population

(kV/cm)

Deviation

Trial 1

Trial 2

Trial 3

Trial 4

Trial 5

0

1.93

1.84

1.85

2.18

1.99

1.96

0.12

2.5

1.70

2.03

2.18

1.64

2.18

1.94

0.23

5

1.56

1.76

1.96

1.64

1.88

1.76

0.15

10

1.36

1.85

1.73

1.55

1.96

1.69

0.21

20

2.50

1.24

1.39

1.13

1.04

1.46

0.53

30

1.39

1.34

1.30

1.01

0.99

1.21

0.17

(millions)

As seen from the table above, the increasing field strengths are responsible for the death of
more and more cells for just 5 pulses, confirming what was suspected by Kolb et. al. [75], who
examined the effects of increased number of pulses causing cell death but hypothesized that by
applying the scaling laws of [47], an increased death would be seen for increased field strengths.
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Immunostaining The increased proliferation can be seen under immunostaining, with the
red marking the actin fibers that begin to differentiate into muscle strands between cells, and blue
marking the nuclei of the cells.
The images below are of the Control sample, with each image taken from a different well
of a 24 well cell culture dish. Between 4-5 images were taken of each well and combined to form
a composite image of each well.

Figure 23: Fluorescent immunostaining of Myoblast cells, Control sample.
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Figure 24: Fluorescent immunostaining of Myoblast cells, 5 kV/cm for 5 pulses.

Figure 25: Fluorescent immunostaining of Myoblast cells, 25 kV/cm for 5 pulses.
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Figure 26: Image with control, 5 kV/cm and 25 kV/cm pulses listed, indicating increased
differentiation for the 5 kV/cm x 5 pulses treatment, with lowered cell counts and differentiation
for 25 kV/cm pulses.
The differentiation above was induced by the addition of differentiating media added at 48
hours after experiment. The initial myoblast cells that were plated (as seen in figure 9) see their
actin fibres grow and combine with fibres from other cells to form muscle strands called myotubes.

Discussion & Conclusion
Applying either five 2.5 kV/cm or 5 kV/cm increased the proliferation of primary mouse
myoblast stem cells with higher field strengths increasing cell kill off up to 25% for five 20 kV/cm
pulses. Thus, these results indicate that there is a regime of lower energy EPs that can stimulate
myoblasts and osteoblasts, boosting their growth rates. The 0 hour counts of cells, stained four
hours after pulsing (allowing enough time for the cells to adhere to the surface of the cell culture
dish) show that the cell population growth does not differ statistically significantly from the initial
plated quantity of cells of the control sample. This could imply an increased growth of the cells
immediately post pulsing. Similar results were seen for the osteoblast cell line. Further, the
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formation of nodules was observed within a 48 to 72 hour period for the lower field strengths, and
not seen for the control, implying an ability of these NSEPs to influence the differentiation of these
cells as seen in [22].
The immunostaining images revealed increased proliferation of cells that may have
induced increased differentiation. Prior research [3] found that while ion movement caused due to
field application was responsible for currents that affected transmembrane voltage, which can be
a deciding factor in determining the direction that mesenchymal stem cells take [5], Ca2+ release
from intracellular stores determined growth kinetics. It is possible a similar release of radicals and
inhibition or activation of other protein markers is likely responsible for the enhanced growth and
onset of differentiation, since the primary target of these pulses is the cell and intracellular
organelle membranes. This is further confirmed by [4], [5], [12] who observed the influence of
field application on transmembrane potentials and the corresponding effect on growth and
differentiation.

Future work and implications
Initial tests have revealed that a low electric field with a low number of pulses leads to
increased proliferation of stem cells, with higher fields responsible for increased cell death. There
is evidence of increased proliferation of myoblast cells in a 48 hour time period but longer term
studies are required to obtain a better picture. A more marked effect of these NSEPs on osteoblast
growth clearly reveals that a similar mechanism may be influencing both cell lines, and this points
to a membrane potential effect. Further, the onset of differentiation in both myoblasts (with the
formation of myotubes) and osteoblasts (with the formation of nodules) adds to this hypothesis.
The clinically relevance of this study would be the potential application in therapeutics and
regeneration therapy, as accelerated growth overcomes any initial kill off due to the low field
treatment. In the case of the osteoblasts, the nodule formation is seen within 48 hours.
Further tests need to be run with samples combining differentiating and non-differentiating
media, to determine if differentiation rate is further enhanced in combination with these NSEPs
(similar to a synergistic effect).
Polymerase chain reaction (PCR) tests will also be run to amplify segments of DNA that
may be inducing differentiation, to see if this is indeed the case. Initial tests proved inconclusive
due to our inability to target a particular gene expression/DNA sequence, and this method needs
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further refinement and study to determine which sequences need to be targeted. due to our inability
to target a particular gene expression/DNA sequence, and this method needs further refinement
and study to determine which sequences need to be targeted.
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4. SYNERGISTIC ENHANCEMENT OF ANTIBIOTIC
SUSCEPTIBILITY OF GRAM POSITIVE AND GRAM NEGATIVE
BACTERIUM USING NANOSECOND PULSED ELECTRIC FIELDS

Introduction.
Antimicrobial resistance (AMR) is a major challenge and growing global health crisis [1], with
many scientists and public health professionals sounding the alarm on a “post-antibiotic” era.
Alexander Fleming, the discoverer of penicillin, predicted such an eventuality in his Nobel Prize
speech in 1945 [2] with antibiotic resistant strains emerging within months to years of the
widespread adoption of antibiotics [3], [4]. The rampant misuse of antibiotics in the livestock
industry to compensate for overcrowded and unsanitary conditions, the use of over the counter
antibiotics, and unnecessary prescription of antibiotics have further compounded these problems
[5].

The paucity of new antibiotics and lack of international coordination to fund drug

development programs or prevent antibiotic overuse have exacerbated AMR. A 2014 World
Health Organization (WHO) report calls AMR a catastrophe waiting to happen and recommends
building a global task force to address the crisis [4].
While the Center for Disease Control (CDC) and WHO have issued statements and
guidelines concerning antibiotic use and antibiotic resistant microbes and initiated tracking
protocols at medical facilities, this does not fully address the underlying causes for resistance
development and emergence [6]. The overuse of antibiotics in agriculture and medicine [7] is a
key driver of antibiotic resistance and high production animal farming methods promote the spread
of disease in overcrowded spaces. To fight infections, farmers have turned to the widespread use
of antibiotics, often at ineffective levels that allow the bacteria to more easily develop resistance[8].
In medical settings, antibiotics are often prescribed for non-bacterial infections. Additionally,
doctors frequently apply broad spectrum antibiotics rather than identifying the causative organism
and applying a targeted targeting treatment due to the lack of rapid, low-cost testing methods[9].
Patients often stop taking medication upon becoming asymptomatic; however, the surviving
microorganisms acquire resistance to subsequent treatments with the same antibiotic.
The scientific and medical communities are currently exploring methods to combat this
problem, including the development of new monitoring and diagnostic tools to improve data
collation [10], in vitro systems to mimic evolutionary environments to determine the time between
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antibiotic susceptibility and resistance, and methods to interfere with existing resistance
mechanisms while simultaneously developing new antibiotics [11]. The latter method is one of
escalation, since any use of antibiotics in humans or animals breeds resistance in the surviving
microbes, which can acquire transmittable genetic material. Subsequent generations of these
surviving microbes requires higher doses of that antibiotic, ultimately necessitating the
development of a new class of antibiotics. While new techniques, such as detecting antimicrobial
compounds as they are produced in their natural environment in the soil instead of a Petri dish
using electronic chips [12], will facilitate antibiotic development, these methods will inevitably
result in stronger, more resistant superbugs.
Since Sale and Hamilton demonstrated that electric pulses (EPs) could eradicate
microorganisms by inducing lysis [13]–[15], researchers have explored EPs for multiple medical
and biological applications, including extending food shelf life [16], permeabilizing cells to
facilitate gene and molecular delivery [17], permeabilizing tumors to facilitate the delivery of
chemotherapeutics [18], and directly killing tumors through irreversible electroporation [19].
These applications typically involve direct EP targeting of cell membranes using electric fields of
hundreds of V/cm to a few kV/cm with durations from microseconds to milliseconds. Technology
development over the past two decades has led to the biomedical application of nanosecond EPs
(NSEPs) with field strengths ranging from tens of kV/cm to a few hundred kV/cm [20]. These
shorter durations enable charging intracellular membranes prior to the cell membrane, permitting
intracellular manipulation with minimal cell membrane impact[20]; however, NSEPs still can
create small pores in the cell membrane[21]. Moreover, NSEPs induce higher temperature
gradients [22] and pressure transients [23] compared to conventional electroporation pulses, which
may further enhance their membrane effects.
While multiple studies have explored EPs for eradicating microorganisms with and without
drugs [24]–[26], this study assesses the feasibility of reducing drug dose and EP energy input to
synergistically apply clinical to prophylactic doses of drugs to clinically relevant gram positive
and gram negative bacteria. Synergistic treatment times on the order of minutes can replace what
traditional antimicrobial therapy accomplishes in hours to days. The novel approach discussed here
could provide a means to treat AMR bacteria by enhancing the antimicrobial effect of antibiotics.
New drug development is still needed but this technique can be applied to better utilize existing
antimicrobial drugs without resorting to last line of defense antimicrobials.
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Materials and Methods
4.2.1

Equipment.

This study utilized a capacitor based Blumlein pulse generator with a spark gap switch to produce
trapezoidal EPs of 300 ns duration at the peak with rise and fall times close to 50 ns. Multiple
pulses were delivered at a frequency of 1 Hz.
The samples were treated in a standard electroporation cuvette (Dot Scientific ®) whose
resistance must match the pulse generator’s impedance to prevent pulse reflection. Utilizing Luria
broth, containing 0.5% NaCl, in a cuvette with gap distances of 1 mm and 2 mm yielded the best
electrical match (no reflections in the measured signal). We used 2 mm cuvettes to ensure
consistency between tests, and the applied voltage was measured across the cuvette using a LeCroy
PPE 20 kV high voltage probe with a 1000:1 attenuation feeding into a TeleDyne LeCroy ®
Waverunner 6 Zi Oscilloscope capable of measuring signals up to 4 GHz. Assuming a purely
parallel plate geometry with minimal fringing gives an electric field E = V/d, where V is the peak
voltage of the applied pulse and d is the gap distance.
4.2.2

Sample Preparation.

These experiments assessed Stapphylococcus aureus (gram positive bacterium number 25923)
from ATCC® and Esherichia coli (gram negative bacterium number 25922) inoculated in luria
broth (LB Broth Lennox, powder microbial growth medium, SIGMA-ALDRICH ®) by taking 8
mL of broth in a 50 mL sterile conical tube and incubating in a shaker for 20 h at 37°C. The sample
was then diluted with fresh Luria broth until attaining an optical density of 0.25 for 100 µL on a
photospectrometer (Molecular Devices) for a wavelength of 562 nm as measured in a 96-well plate.
The optical density, which varies with growth or tube volume, was determined experimentally and
set between 1 × 108 and 1.5 × 108 colony forming units (CFUs)/mL for the samples to be pulsed.
These samples were then plated at dilutions between 10-6 and 100 (no dilution) depending on the
effectiveness of the pulse treatments.
4.2.3

Electric Pulse Treatment Protocol.

Bacterial samples were then placed into the 2 mm cuvettes and treated with various EP parameters
determined comparable to those in the literature [76] and selected such that that the highest electric
fields induced clinically relevant inactivation (4 log-10) and lower electric fields induced
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insignificant inactivation (less than 0.3 log-10, or 30%). Although no consensus exists on a
universal scaling law for applied EP “dose,” we fixed the energy density
U = TNE2,

(1)

where N is the number of pulses and T is the pulse duration [47]. Fixing U for E = 40, 30, and 20
kV/cm gave N = 250, 445, and 1000 pulses, respectively. Cultures were plated as described below.
One must take care when filling cuvettes as a failure to exactly cover the electrodes with
sample can expose them to air, which can cause dielectric breakdown (arcing) at higher electric
fields, while overfilling the cuvette may result in cells unexposed to the full electric field and
artificially reduce the measured microorganism inactivation [77]. Filling each cuvette with 365
L of sample (sufficient to just cover the electrodes) and then placing 250 L of molecular
biology grade mineral oil on top mitigated these challenges. Keeping the samples on ice upon
achieving the required dilution further reduced experimental variability by slowing biological
processes, such as fission. This facilitated the assessment of the inactivation efficiency of EPs,
drugs, and combined treatments.
Tests used the clinically relevant, bactericidal drug tobramycin, which targets the 30S and
50S ribosome complex and has a clinical dose from 4 to 5 µg/mL [78]. We added 0.2, 2, and 20
µg/mL of tobramycin to the initial bacterial dilutions prior to pulsing. We immediately placed
these samples on ice to minimize cell division and reduce variability. These aliquots were also
used to plate individual unpulsed controls for each drug concentration.
4.2.4

Plating.

Plating was done on standard disposable tissue culture Petri dishes from VWR (15 cm diameter,
10 mm height) and covered with 10 mL of agar in luria broth (Agar, microbiology tested powder,
SIGMA-ALDRICH ®), which was prepared by adding 20 g of LB lennox (SIGMA-ALDRICH)
and 15 g/L of agar to water and then autoclaved.
We plated samples at dilutions of 10-6 and 10-3 for low and high electric field treatments,
respectively, and at 10-6 and 10-5 for controls. All samples containing 100 µL of pulsed or diluted
cultures were plated on LB agar plates and counted after overnight incubation at 37 °C.We plated
samples at dilutions of 10-6 and 10-3 for low and high electric field treatments, respectively, and at
10-6 and 10-5 for controls. All samples containing 100 µL of pulsed or diluted cultures, were plated
on LB agar plates and counted after overnight incubation at 37 °C.
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Results.
We treated three replicates to obtain a sufficient sample size to determine the standard deviation
(SD) of each point. We report SD for all error bars and uncertainty in all reported data.
4.3.1

Pulsing without drugs
We first assess the impact of EPs on colony forming units (CFUs) and serve as a baseline

for comparing experiments combining EPs and drugs.

Table 1 summarizes the resulting

population reduction for both S. aureus and E. coli for six replicates for the control and 20 kV/cm
conditions and four replicates for the 30 kV/cm and 40 kV/cm experiments. EPs induced greater
cell death for E. coli than for S. aureus until the 40 kV/cm. Despite each treatment delivering the
same energy density, the applied electric field clearly drove the resulting cell death, as observed
previously when assessing the impact of bipolar EP induced ion transport [27] for each
microorganisms with the effect starting to plateau at 40 kV/cm for E. coli. The rapid increase in
CFU reduction observed from 20 kV/cm to 30 kV/cm for each microorganism suggests a threshold
for membrane effects. Most studies indicate that electroporation threshold occurs for membrane
voltages on the order of a few hundred millivolts with longer durations and higher voltages
responsible for making this permeabilization irreversible. Since the time between the pulses is
long (~1 s) compared to the typical membrane pore lifetimes (particularly for nanosecond duration
EPs).
Thus, simply applying additional lower intensity EPs, even when these pulse train deposits
the same total energy as the higher intensity EP train, is inadequate to inactivate microorganisms.
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Table 5: Electric pulse parameters and the subsequent reduction in S. aureus and E. coli
populations.
Electric Field
(kV/cm)

# Pulses

Log reduction of
S. aureus

Log reduction of
E. coli

0

0

0.0±0.0

0.0±0.0

20

1000

0.2±0.1

1.42±0.39

30

445

2.9±0.7

3.26±0.30

40

250

3.7±0.7

3.81±0.0

This suggests that the time between the pulses (~1 s) is sufficiently long compared to the membrane
pore lifetimes (particularly for nanosecond duration EPs, which typically create smaller pores than
conventional electroporation) for additional EPs to further permeabilize the membrane.
4.3.2

Pulsing with drugs.

Bacterial samples of both gram positive S. aureus and gram negative E. coli strains were pulsed in
a solution with drugs at the different concentrations presented in Table 2 and compared to an
unpulsed drug-exposed control. Pulsing and plating were performed to ensure that the drug
exposure time of the bacteria was approximately fifteen minutes.
Fig. 1 shows that combining trains of 300 ns EPs with tobramycin induces significantly
greater inactivation of S. aureus than the antibiotic alone. As noted above, even though each train
of pulses delivered the same total energy to the sample, the greatest synergy and microorganism
inactivation arose for the higher electric fields strengths. Combining the 20 kV/cm EPs with no
drug or 0.2 µg/mL induced a 10-20% reduction in S. aureus population. Combining these EP with
higher, clinically relevant concentrations of 2 µg/mL and 20 µg/mL resulted in 1.5 and 2.6 logreduction, respectively, which were statistically significant compared to treatments of just
tobramycin. Although the 30 kV/cm and 40 kV/cm conditions resulted in statistically significant
inactivation compared to the untreated control, microorganism inactivation still increased with
increasing concentration of tobramycin.
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Figure 27: Combining trains of 300 ns electric pulses with the same energy, but different electric
fields, with different concentrations of the tobramycin synergistically inactivated S. aureus.
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Figure 28: Combining trains of 300 ns electric pulses with the same energy, but different electric
fields, with different concentration of the antibiotic tobramycin synergistically inactivated E. coli
with the effect stronger for higher electric fields.
Similarly, Fig. 2 shows that combining trains of 300 ns EPs with 2 and 20 µg/mL of the
bactericidal tobramycin induces significantly greater inactivation of E. coli than the antibiotic
alone. For 0.2 µg/mL tobramycin, 20 kV/cm did not show synergy but the 30 and 40 kV/cm did
show synergy. The EPs induce a noticeably greater inactivation of E. coli than S. aureus. The 20
kV/cm condition induced a statistically significant reduction of 1.4 log-10 for the E. coli samples
with no drug compared to sub-log reduction observed for S. aureus. Likewise, the 30 kV/cm
treatment with no drug induced a 3.5 log-reduction of CFUs, which is a full log-reduction more
compared to the S. aureus. We do not report the results for the 40 kV/cm condition as combining
these EPs with antibiotics resulted in reductions of over 9 log-10 and was considered a complete
sterilization of the E. coli.
microorganism inactivation.

As for S. aureus, increasing the drug concentration enhanced
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Discussion.
Some bacteria have inherent resistance to certain antibiotics based on structural differences
between gram-positive and gram-negative bacteria [5]. For some, the cell membrane acts as a size
exclusion filter that limits solutes that can enter the cell. The classic example of this is the
exclusion of penicillin G from the peptidoglycan layer of gram-negative bacteria by the size of
porins in the outer membrane [5], [6]. Contrary to this passive mechanism, active resistance
mechanisms require energy input by the cell to defeat an antibiotic. Many early beta-lactam
antibiotics are susceptible to inactivation by a lactamase enzyme that cuts the beta-lactam ring [9].
The addition of chemical groups to antibiotics by enzymes can also inhibit drug function by
preventing binding to the target site [3]. For instance, vancomycin binds to a crosslinking site in
the peptidoglycan layer. Mutations in this site prevent vancomycin from binding while still
permitting crosslinking of the peptidoglycan layer to strengthen the cell wall [6]. Multidrug
resistant pumps provide another major mechanism of resistance [28]. Originally used by bacteria
to actively move various molecules into or out of a cell, mutations have modified the pumps so
that they can lower the internal concentration of the drug below the level required for it to be
effective. This, in turn, necessitates a much higher external concentration of drug to achieve the
desired effect[8].
The more complicated the resistance mechanisms, the longer it takes for clinical resistance
to arise, such as for vancomycin resistance. However, the more bacteria that are working on the
problem, the more rapidly a solution will be found. This is accomplished through the widespread
use of antibiotics in agriculture and medicine. Once a useful solution is developed by a given
bacteria, it will quickly spread through cell division and lateral transfer of plasmids, including
lateral transfer to different species of bacteria. This underscores the need for a technology that can
bypass and undermine the evolved resistance mechanisms developed by these cells by essentially
“short circuiting” these defenses against antibiotics.
These mechanisms demonstrate the importance of the synergy induced by combining EPs
with antibiotics. While previous studies have examined the inactivation mechanics of NSEPs on
bacterial cells [25], [29], [30], the current study demonstrates that combining clinically relevant
doses of antibiotics with NSEPs to treat clinically relevant bacteria with induced synergistic
inactivation, even up to complete sterilization in vitro, within fifteen minutes of treatment.
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The 300 ns EPs more effectively inactivated E. coli than S. aureus. This is largely due to
the size difference between gram positive and gram negative bacteria, with gram positives being
smaller in size, ~500 nm in diameter. E. coli is a gram negative rod with a diameter of ~500 nm
and a length of ~1500 nm, roughly 2.5 times the size of S aureus. Another major difference
between gram positive and gram negative bacteria is the internal hyperosmotic gradient maintained
by the cell. Gram positive bacteria have a hyperosmotic gradient roughly double that of gram
negative bacteria[1]. Gram positive bacteria have a single cell membrane and use the osmotic
pressure induced by the hyperosmotic gradient to maintain the volume of the cell. Gram negative
E. coli has two cell membranes and a peptidoglycan layer sandwiched in between them. This
gram-negative cell wall structure is more rigid and does not require as strong of a hyperosmotic
gradient to maintain the shape of the cell. Since S. aureus is also smaller, it requires a higher
applied electric field to achieve the membrane voltage necessary for electropermeabilization [31].
Concomitantly, its smaller size means that a given applied electric field will create a lower number
of pores on the surface area than E. coli, implying a lesser area for ions and intracellular
compounds to flow across the membrane than for E. coli. All these factors may contribute to the
difference in treatment effectiveness.
We quantify synergy as the additional inactivation induced by the antibiotic for a given
pulse condition. While the standard clinical dose of 4-5 µg/mL of tobramycin induces a noticeable
kill-off of bacteria, it takes many hours to see this effect, combining even a 1/20th (0.2 µg/mL) of
this dose with a train of NSEPs causes a 1.5 to 2.5 log-reduction after only ten minutes of exposure
to the antibiotic. Fig. 3 shows the resulting synergy for tobramycin for the EP parameters described
above. For S. aureus (fig 3a), no synergy occurred for the 20 kV/cm pulse trains for tobramycin
concentrations at 0.2 µg/mL, while 2.0 µg/mL resulted in 1.5 log synergy. For the 30 kV/cm and
40 kV/cm pulse trains, synergies occurred for all 2 and 20 µg/mL doses tobramycin and increased
with increasing concentration of tobramycin. Interestingly, the synergy for tobramycin
concentration at or above 2 µg/mL was essentially independent of the applied field, although the
net inactivation depended strongly on the applied electric field [c.f. Fig. 1]. For E. coli, Fig. 3b
shows that pulse trains using any of the applied electric fields experienced synergy for any
tobramycin concentration with the synergy increasing for increasing drug concentration and
relatively insensitive of applied field for both the 20 kV/cm and 30 kV/cm cases. In this case, the
synergy appears to decreases for the 40 kV/cm train when tobramycin concentration is increased
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from 0.2 to 2.0 µg/mL. This occurs because the total number of viable cells after 40 kV/cm
treatments is less than two log from the original nine log of cells at the beginning of the experiment.
Thus, the synergistic kill-off appears lower. A greater concentration of cells or fewer applied
pulses would be necessary to determine the synergy of 40 kV/cm and tobramycin. The error was
calculated from the standard deviation that results from propagation due to subtraction between
quantities as δ Q = (δ a)2 + (δ b) 2 .

Figure 29: The synergistic inactivation of antibiotic tobramycin combined with 300 ns EPs for
(a) S. aureus and (b)E. coli.
Tobramycin uptake disrupts the 50S and 30S ribosome complex responsible for translating
mRNA into proteins [31]. The inability to replace damaged proteins leads the death of the bacteria.
The observed synergy arises because the EPs disrupt the cell membrane’s barrier function, which
allows the antibiotic to diffuse into the cell at a much higher rate than an intact cell membrane.
This culminates in an antibiotic concentration sufficient to induce a bactericidal result [4].
While one may consider synergy as increasing inactivation by incorporating NSEPs to
antibiotic treatment, viewing synergy as a method of boosting antibiotic effectiveness by reducing
time to action has serious implications in infection treatment. Inducing the effect that an antibiotic
would have over a 12 or 24 hour period in a matter of seconds to minutes dramatically reduces
treatment time, which can be critical for fast-acting infections or infections that are difficult to treat
with such slow treatment modalities, such as those causing rapid cellulitis. Boosted synergy also
implies that lower doses of last-line of defense drugs, which can have serious side effects, can be
used to produce the same effects as current clinical doses or prophylactic dose levels. The ability
of EPs to permeabilize bacterial membranes to improve the effectiveness of antimicrobials may
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reduce the number of cells available to develop resistance. This could have an enormous impact
on AMR by providing existing antibiotics an ability to overcome resistance mechanisms developed
by bacteria. However, this does not include drugs that rely on growth mechanisms to kill the cell,
such as penicillin, or drugs that act outside of the cell membrane.
The entire process, including pulsing the sample, diluting and plating the colonies takes
fifteen minutes. Synergy occurred for 1/20th, 0.2 µg/mL, of the recommended clinical dose of
tobramycin, 4 µg/mL, with dramatic synergy arising for higher doses. The significance of this EPinduced synergy is twofold. First, this process will reduce the antibiotic dose and electrical energy
input needed to treat infections. Second, the EP may weaken the microorganisms or sufficiently
facilitate passive drug transport into the cell to allow the application of antibiotics usually
ineffective against certain types or strains of bacteria due to the drug’s size or resistance
mechanisms present in the bacteria.
Using EPs to restore the antibacterial properties of antibiotics that have become ineffective
due to AMR or to lower the doses of current antibiotics needed to treat an infection, which
consequently mitigates potential side effects, will have a significant impact on treating the growing
number of antibiotic resistant infections. This new approach of combining an electric stimulus
with ineffective antibiotics may provide a way to avoid, or at least delay, a “post-antibiotic” era,
to provide precious time needed for new drug and treatment development. Future studies may
optimize EP parameters, explore different drugs, and assess the efficacy for treating various
microorganisms in vitro and in vivo.

Future Work
Tests are currently underway to examine the effects of multiple drugs, to target different
complexes in the bacterium and weaken them for lower doses. This enhanced synergy for a
combination of drugs will allow the combination of drugs to be tailored depending on the
resistance mechanism developed, and also determine which the use of drugs on the basis of their
mechanism of action.
Future tests will also examine the effects of a series of drugs on a range of different, clinically
relevant bacteria, including biofilms, which are a source of great concern for the biomedical
implants and devices industry, due to their ability to generate infections that require surgical
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removal of the implants. The formation of a biofilm also results in the creation of a matrix that is
likely to be more resistant to field penetration.
Preliminary tests have also been conducted on superbugs, or antibiotic resistant bacteria.
This data will need to be reproduced in triplicate, and included in the final version of this document.
Successful elimination of superbugs by boosting the effect of antibiotics will have huge
implications especially in the fields of surgery and biomedical implants.
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5. FUTURE WORK

The population dynamics work was constantly revised due to experimental refinements to
minimize variation and human factors involved in assessing the populations, thereby reducing the
error in the population count. It was also expanded to include clinically relevant parameters[56],
and when further studies revealed a threshold below which there was no recovery, it was expanded
to study that region.
Future work will include the extraction of parameters from these curves to use in the model
described above[50], to determine the properties of the different functions and thus, giving us an
understanding of how growth is affected and changed.
Initial tests of the stem cells have revealed that a low electric field with a low number of
pulses leads to increased proliferation of stem cells, with higher fields responsible for increased
cell death. There is no evidence of increased proliferation of those cells in a 48 hour time period,
for which longer term studies are required. Similarly, long term population studies may reveal an
increased proliferation rate in experiments done in the phase 2 manner, which are more clinically
relevant, since they account for cells that have died, showing the same rate of growth across all
samples in a 48 hour time period.
Further tests need to be run with samples combining differentiating and non-differentiating
media, to determine if these pulses are inducing differentiation. The next phase of this study is to
plate samples which will have differentiation media added to half of the wells, to determine if
differentiation is indeed induced, or merely a result of increased proliferation of the cells.
Polymerase chain reaction (PCR) tests will also be run to amplify segments of DNA that
may be inducing differentiation, to see if this is indeed the case. Initial tests proved inconclusive
due to our inability to target a particular gene expression/DNA sequence, and this method needs
further refinement and study to determine which sequences need to be targeted.
To extend the microorganism inactivation work, tests are currently underway to examine the
effects of multiple drugs, to target different complexes in the bacterium and weaken them for lower
doses. This enhanced synergy for a combination of drugs will allow the combination of drugs to
be tailored depending on the resistance mechanism developed, and also determine which the use
of drugs on the basis of their mechanism of action.
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Future tests will also examine the effects of a series of drugs on a range of different, clinically
relevant bacteria, including biofilms, which are a source of great concern for the biomedical
implants and devices industry, due to their ability to generate infections that require surgical
removal of the implants. The formation of a biofilm also results in the creation of a matrix that is
likely to be more resistant to field penetration.
Preliminary tests have also been conducted on superbugs, or antibiotic resistant bacteria. This data
will need to be reproduced in triplicate, and included in the final version of this document.
Successful elimination of superbugs by boosting the effect of antibiotics will have huge
implications especially in the fields of surgery and biomedical implants.
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